Status:
ACTIVE_NOT_RECRUITING
Impact of Covid-19 on Syphilis
Lead Sponsor:
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Conditions:
Syphilis
COVID - 19
Eligibility:
All Genders
18+ years
Brief Summary
Sexually transmitted infections (STIs) represent a significant challenge to global public health. Although many of these infections are treatable, failure to diagnose and delayed treatment can lead to...
Detailed Description
Syphilis is a chronic infectious disease with a prolonged course, characterized by considerable clinical variability, so much so that it is referred to as the great imitator, due to its ability to man...
Eligibility Criteria
Inclusion
- Patients aged ≥18 years
- Patients with microbiological and/or clinical diagnosis of syphilis
- Patients treated by the Infectious Diseases Department of the University Hospital of Alessandria
- Signature of informed consent form
Exclusion
- Patients for whom the data required for the study are not available in medical records or electronic filing systems
Key Trial Info
Start Date :
May 28 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 28 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT07150871
Start Date
May 28 2025
End Date
May 28 2026
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center
Alessandria, Piedmont, Italy, 15121